Pioglitazone strengthen therapeutic effect of adipose-derived regenerative cells against ischemic cardiomyopathy through enhanced expression of adiponectin and modulation of macrophage phenotype

[1]  H. Yim,et al.  Mesenchymal Stem Cell Therapy for Ischemic Heart Disease: Systematic Review and Meta-analysis , 2018, International journal of stem cells.

[2]  Yuehua Wu,et al.  Pioglitazone stabilizes atherosclerotic plaque by regulating the Th17/Treg balance in AMPK-dependent mechanisms , 2017, Cardiovascular Diabetology.

[3]  Y. van der Graaf,et al.  Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials , 2017, Cardiovascular Diabetology.

[4]  Ling Wei,et al.  Priming of the Cells: Hypoxic Preconditioning for Stem Cell Therapy , 2017, Chinese medical journal.

[5]  T. Cahill,et al.  Heart regeneration and repair after myocardial infarction: translational opportunities for novel therapeutics , 2017, Nature Reviews Drug Discovery.

[6]  T. Funahashi,et al.  The unique prodomain of T-cadherin plays a key role in adiponectin binding with the essential extracellular cadherin repeats 1 and 2 , 2017, The Journal of Biological Chemistry.

[7]  J. Boeynaems,et al.  Mouse P2Y4 Nucleotide Receptor Is a Negative Regulator of Cardiac Adipose-Derived Stem Cell Differentiation and Cardiac Fat Formation. , 2017, Stem cells and development.

[8]  T. Funahashi,et al.  Adiponectin association with T‐cadherin protects against neointima proliferation and atherosclerosis , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  J. Leor,et al.  Macrophages and regeneration: Lessons from the heart. , 2016, Seminars in cell & developmental biology.

[10]  S. Prabhu,et al.  The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. , 2016, Circulation research.

[11]  A. Sowińska,et al.  The Correlation of PPARα Activity and Cardiomyocyte Metabolism and Structure in Idiopathic Dilated Cardiomyopathy during Heart Failure Progression , 2016, PPAR research.

[12]  I. Shimomura,et al.  Adipose tissue macrophages induce PPARγ-high FOXP3+ regulatory T cells , 2015, Scientific Reports.

[13]  R. de Caterina,et al.  Transplantation of adipose tissue mesenchymal cells conjugated with VEGF-releasing microcarriers promotes repair in murine myocardial infarction. , 2015, Cardiovascular research.

[14]  A. J. Lusis,et al.  Macrophage polarization phenotype regulates adiponectin receptor expression and adiponectin anti‐inflammatory response , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  I. Shimomura,et al.  Targeted delivery of adipocytokines into the heart by induced adipocyte cell-sheet transplantation yields immune tolerance and functional recovery in autoimmune-associated myocarditis in rats. , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[16]  T. Funahashi,et al.  High serum C1q-binding adiponectin levels in male patients with acute coronary syndrome , 2014, Cardiovascular Diabetology.

[17]  S. Miyagawa,et al.  Present and Future Perspectives on Cell Sheet-Based Myocardial Regeneration Therapy , 2013, BioMed research international.

[18]  Abul Kashem,et al.  Present status and future perspectives of heart transplantation. , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[19]  Haiyun Huang,et al.  The Relative Contribution of Paracine Effect versus Direct Differentiation on Adipose-Derived Stem Cell Transplantation Mediated Cardiac Repair , 2013, PloS one.

[20]  T. Funahashi,et al.  Cardiovascular-metabolic impact of adiponectin and aquaporin. , 2013, Endocrine journal.

[21]  P. Doevendans,et al.  Cardiac stem cell therapy to modulate inflammation upon myocardial infarction. , 2013, Biochimica et biophysica acta.

[22]  Meilian Liu,et al.  Up- and down-regulation of adiponectin expression and multimerization: mechanisms and therapeutic implication. , 2012, Biochimie.

[23]  Y. E. Chen,et al.  PPARs and the cardiovascular system. , 2009, Antioxidants & redox signaling.

[24]  N. Frangogiannis.  The immune system and cardiac repair. , 2008, Pharmacological research.

[25]  F. Prósper,et al.  Transplantation of adipose derived stromal cells is associated with functional improvement in a rat model of chronic myocardial infarction , 2008, European journal of heart failure.

[26]  Francis G Spinale,et al.  Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. , 2007, Physiological reviews.

[27]  A. Schäffler,et al.  Concise Review: Adipose Tissue‐Derived Stromal Cells—Basic and Clinical Implications for Novel Cell‐Based Therapies , 2007, Stem cells.

[28]  S. Kihara,et al.  Adiponectin-mediated modulation of hypertrophic signals in the heart , 2004, Nature Medicine.

[29]  Keith L. March,et al.  Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells , 2004, Circulation.

[30]  M. Matsuda,et al.  Role of Adiponectin in Preventing Vascular Stenosis , 2002, The Journal of Biological Chemistry.

[31]  G. Goings,et al.  T-cadherin Is a Major Glycophosphoinositol-anchored Protein Associated with Noncaveolar Detergent-insoluble Domains of the Cardiac Sarcolemma* , 1998, The Journal of Biological Chemistry.

[32]  C M O'Connor,et al.  Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. , 1997, Journal of the American College of Cardiology.

[33]  T. Funahashi,et al.  cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). , 1996, Biochemical and biophysical research communications.

[34]  T. Funahashi,et al.  Cardiovascular-metabolic impact of adiponectin and aquaporin [Review] , 2013 .